Status:
COMPLETED
Transcranial Magnetic Stimulation for BECTS
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Benign Epilepsy With Centrotemporal Spikes
Language Problems
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
Benign epilepsy with centrotemporal spikes (BECTS) is the most common pediatric epilepsy syndrome. Affected children typically have a mild seizure disorder, but yet have moderate difficulties with lan...
Eligibility Criteria
Inclusion
- A diagnosis of Benign Epilepsy with Centrotemporal Spikes (BECTS), sometimes called Rolandic Epilepsy. Diagnosis will be based on a history of a focal motor seizure (affecting the face or causing hypersalivation) or a history of a seizure out of sleep AND an EEG with unilateral or bilateral centrotemporal spike waves.
- English-speaking
Exclusion
- History of prematurity \< 35 weeks gestational age;
- History of serious neurologic problems (i.e. history of other seizure disorder other than simple febrile seizure, head trauma with prolonged loss of consciousness, cerebrovascular accident or neuro-inflammatory disease)
- Focal deficits on neurologic exam
- History of abnormal MRI (with clear gray or white matter abnormality)
Key Trial Info
Start Date :
October 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04325282
Start Date
October 28 2020
End Date
March 3 2024
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Palo Alto, California, United States, 94304